John A. MacPhee, EVP, Pres-Strativa at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 39,910 shares at $24.89 ($998K) on 2010-03-09, disclosed to the SEC on 2010-03-10.
Seasonal sale ($998k) by EVP, Pres-Strativa — this insider has traded PRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.87 | 800 | $20K | 2.0% |
| 2 | $24.88 | 200 | $5K | 0.5% |
| 3 | $24.89 | 300 | $7K | 0.7% |
| 4 | $24.91 | 700 | $17K | 1.7% |
| 5 | $24.92 | 200 | $5K | 0.5% |
| 6 | $24.93 | 200 |
| $5K |
| 0.5% |
| 7 | $24.94 | 200 | $5K | 0.5% |
| 8 | $24.95 | 1,100 | $27K | 2.7% |
| 9 | $24.96 | 900 | $22K | 2.3% |
| 10 | $24.97 | 2,400 | $60K | 6.0% |
| 11 | $24.98 | 1,578 | $39K | 3.9% |
| 12 | $24.99 | 3,409 | $85K | 8.5% |
| 13 | $25.00 | 100 | $3K | 0.3% |
| 14 | $25.00 | 3,129 | $78K | 7.8% |
| 15 | $25.01 | 2,800 | $70K | 7.0% |
| 16 | $25.02 | 200 | $5K | 0.5% |
| 17 | $25.02 | 3,802 | $95K | 9.5% |
| 18 | $25.03 | 3,299 | $83K | 8.3% |
| 19 | $25.04 | 100 | $3K | 0.3% |
| 20 | $25.04 | 3,171 | $79K | 8.0% |
| 21 | $25.05 | 7,582 | $190K | 19.0% |
| 22 | $25.06 | 1,935 | $48K | 4.9% |
| 23 | $25.07 | 1,205 | $30K | 3.0% |
| 24 | $25.08 | 400 | $10K | 1.0% |
| 25 | $25.09 | 100 | $3K | 0.3% |
| 26 | $25.10 | 100 | $3K | 0.3% |
| Total | $25.01 avg | 39,910 | $998K | 100% |
| Filing → |
| PRX | BUY | 2007-10-05 | $56K | — | Filing → |